LCTX · Lineage Cell Therapeutics, Inc. · Documents
$1.00
+0.02 (+1.52%)
At close · Oct 23
View the 10-K filed Mar 5, 2026
Return incl. dividend (before tax)
Customer concentration
— top 2 customers 92% of revenue
2 customers — 92% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”
One customer — 92% of revenue (the year ended December 31, 2024)
“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
Market Cap
$252.91M
Shares
252.91M
Volume · Oct 23
1.15M
Avg daily vol (3M)
1.25M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEF 14A | — | 2021-08-03 | — | |
| 8-K | — | 2021-07-21 | 2021-07-20 | |
| 8-K | — | 2021-06-16 | — | |
| 8-K | — | 2021-06-01 | — | |
| 8-K | — | 2021-05-13 | — | |
| 10-Q | — | 2021-05-13 | 2021-03-31 | |
| 8-K | — | 2021-05-05 | 2021-05-04 | |
| 8-K | — | 2021-05-03 | — | |
| 8-K | — | 2021-04-22 | 2021-04-20 | |
| 8-K | — | 2021-03-29 | — | |
| 8-K | — | 2021-03-26 | 2021-03-23 | |
| 8-K | — | 2021-03-23 | — | |
| S-3 | — | 2021-03-11 | — | |
| S-3 | — | 2021-03-11 | — | |
| 10-K | — | 2021-03-11 | 2020-12-31 | |
| 8-K | — | 2021-03-11 | — | |
| 8-K | — | 2021-03-05 | — | |
| 8-K | — | 2021-01-20 | 2021-01-15 | |
| 8-K | — | 2021-01-06 | — | |
| 8-K | — | 2020-11-16 | — | |
| 8-K | — | 2020-11-12 | 2020-11-11 | |
| 8-K | — | 2020-11-04 | — | |
| 10-Q | — | 2020-11-04 | 2020-09-30 | |
| 8-K | — | 2020-09-23 | 2020-09-22 | |
| 8-K | — | 2020-09-14 | 2020-09-11 | |
| DEFA14A | — | 2020-08-07 | — | |
| DEF 14A | — | 2020-08-07 | — | |
| 8-K | — | 2020-08-06 | — | |
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| 8-K | — | 2020-05-21 | — | |
| 10-Q | — | 2020-05-07 | 2020-03-31 | |
| 8-K | — | 2020-05-07 | 2020-05-06 | |
| S-3 | — | 2020-05-01 | — | |
| 10-K/A | — | 2020-04-28 | 2019-12-31 | |
| 10-K | — | 2020-03-12 | 2019-12-31 | |
| 8-K | — | 2020-03-12 | — | |
| 8-K | — | 2020-01-13 | — |
Showing 101–137 of 137 filings
Key facts
CIK
876343
CUSIP
53566P109
13F (30d)
26 filings
26 filers
Visit website
Investor relations